ClinVar Miner

Submissions for variant NM_001009944.3(PKD1):c.664G>C (p.Ala222Pro)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Fulgent Genetics, Fulgent Genetics RCV005017230 SCV005640631 likely pathogenic Polycystic kidney disease, adult type 2024-05-24 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004726212 SCV005338832 uncertain significance PKD1-related disorder 2024-08-17 no assertion criteria provided clinical testing The PKD1 c.664G>C variant is predicted to result in the amino acid substitution p.Ala222Pro. This variant has been reported in individuals with autosomal dominant polycystic kidney disease (ADPKD) (Liang et al. 2019. PubMed ID: 31730820; Kim et al. 2021. PubMed ID: 32816041). This variant has not been reported in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.